Drug derived from Himalayan fungus shows potency for killing cancer cells

A new study spearheaded by Professor Sarah Blagden and Dr. Hagen Schwenzer, researchers from the University of Oxford, in collaboration with biopharmaceutical company NuCana, has led to a novel chemotherapy drug that demonstrates significant potency in killing cancer cells.

The new drug, called…

Click here to view the original article.